The effect of ethnicity and immigration on treatment resistance in schizophrenia

• Published in: Comprehensive psychiatry Vol. 89; pp. 28 - 32
• Main Authors: Bani-Fatemi, Ali, Tasmim, Samia, Graff, Ariel, Gerretsen, Philip, Dada, Oluwagbenga O., Kennedy, James L., Hettige, Nuwan, Zai, Clement, de Jesus, Danilo, de Bartolomeis, Andrea, De Luca, Vincenzo
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.02.2019; Elsevier Limited; Elsevier
• Subjects: Adult; Antipsychotic Agents - therapeutic use; Antipsychotics; Canada; Cross-Sectional Studies; Drug dosages; Emigrants and Immigrants - psychology; Ethnic Groups - psychology; Ethnicity; European Continental Ancestry Group - psychology; Families & family life; Female; Genealogy; Humans; Immigration policy; Logistic Models; Male; Mental health; Middle Aged; Migration; Minority & ethnic groups; Noncitizens; Patient Acceptance of Health Care - ethnology; Patient Acceptance of Health Care - psychology; Patients; Polypharmacy; Psychotropic drugs; Schizophrenia; Schizophrenia - ethnology; Schizophrenic Psychology; Self Report; Substance abuse treatment; Treatment resistance; Canada; United States > US; Schizophrenia; Antipsychotics; Treatment resistance; Ethnicity; Migration

Treatment resistance is a common issue among schizophrenia patients undergoing antipsychotic treatment. According to the American Psychiatric Association (APA) guidelines, treatment-resistant status is defined as little or no symptom reduction to at least two antipsychotics at a therapeutic dose for...